New research from the IQVIA Institute for Human Data Science shows the significant role that patient organizations play in the US healthcare system.
IQVIA found that, over the past five years, organizations falling into this category have contributed over $22 billion to patient services, research, and access to care, through grants.
There are over 3,000 patient groups in the country, with the 21st Century Cures Act ushering in a “seismic shift” in the role they play through collaborations with drugmakers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze